BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 14736957)

  • 21. Kinin, a mediator of diabetes-induced glomerular hyperfiltration.
    Jaffa AA; Rust PF; Mayfield RK
    Diabetes; 1995 Feb; 44(2):156-60. PubMed ID: 7859934
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Prevention by L-dopa of early renal consequences of diabetes induced by streptozocin in rats].
    Vailly B; Barthelmebs M; Velly J; Grima M; Imbs JL
    Arch Mal Coeur Vaiss; 1990 Jul; 83(8):1259-62. PubMed ID: 2148079
    [TBL] [Abstract][Full Text] [Related]  

  • 23. C-peptide prevents glomerular hypertrophy and mesangial matrix expansion in diabetic rats.
    Samnegård B; Jacobson SH; Jaremko G; Johansson BL; Ekberg K; Isaksson B; Eriksson L; Wahren J; Sjöquist M
    Nephrol Dial Transplant; 2005 Mar; 20(3):532-8. PubMed ID: 15665028
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of C-peptide on renal function at the early stage of experimental diabetes.
    Sjöquist M; Huang W; Johansson BL
    Kidney Int; 1998 Sep; 54(3):758-64. PubMed ID: 9734600
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Beraprost sodium, prostacyclin analogue, attenuates glomerular hyperfiltration and glomerular macrophage infiltration by modulating ecNOS expression in diabetic rats.
    Yamashita T; Shikata K; Matsuda M; Okada S; Ogawa D; Sugimoto H; Wada J; Makino H
    Diabetes Res Clin Pract; 2002 Sep; 57(3):149-61. PubMed ID: 12126764
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Insulin induces the correlation between renal blood flow and glomerular filtration rate in diabetes: implications for mechanisms causing hyperfiltration.
    Pihl L; Persson P; Fasching A; Hansell P; DiBona GF; Palm F
    Am J Physiol Regul Integr Comp Physiol; 2012 Jul; 303(1):R39-47. PubMed ID: 22461175
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of renal denervation on cardiovascular, metabolic and renal functions in streptozotocin-induced diabetic rats.
    de Oliveira TL; Lincevicius GS; Shimoura CG; Simões-Sato AY; Garcia ML; T Bergamaschi C; R Campos R
    Life Sci; 2021 Aug; 278():119534. PubMed ID: 33933461
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Renal effects of plant-derived oleanolic acid in streptozotocin-induced diabetic rats.
    Mapanga RF; Tufts MA; Shode FO; Musabayane CT
    Ren Fail; 2009; 31(6):481-91. PubMed ID: 19839826
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevention of glomerular dysfunction in diabetic rats by treatment with d-alpha-tocopherol.
    Koya D; Lee IK; Ishii H; Kanoh H; King GL
    J Am Soc Nephrol; 1997 Mar; 8(3):426-35. PubMed ID: 9071711
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Disassociation between glomerular hyperfiltration and extracellular volume in diabetic rats.
    Tucker BJ; Collins RC; Ziegler MG; Blantz RC
    Kidney Int; 1991 Jun; 39(6):1176-83. PubMed ID: 1895671
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of neuronal nitric oxide synthase ameliorates renal hyperfiltration in streptozotocin-induced diabetic rat.
    Ito A; Uriu K; Inada Y; Qie YL; Takagi I; Ikeda M; Hashimoto O; Suzuka K; Eto S; Tanaka Y; Kaizu K
    J Lab Clin Med; 2001 Sep; 138(3):177-85. PubMed ID: 11528370
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevention of glomerular hyperfiltration in rats with streptozotocin-induced diabetes by an atrial natriuretic peptide receptor antagonist.
    Sakamoto K; Kikkawa R; Haneda M; Shigeta Y
    Diabetologia; 1995 May; 38(5):536-42. PubMed ID: 7489835
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of the somatostatin analogue octreotide on renal function in conscious diabetic rats.
    Bak M; Thomsen K; Flyvbjerg A
    Nephrol Dial Transplant; 2001 Oct; 16(10):2002-7. PubMed ID: 11572888
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vivo visualization of glomerular microcirculation and hyperfiltration in streptozotocin-induced diabetic rats.
    Satoh M; Kobayashi S; Kuwabara A; Tomita N; Sasaki T; Kashihara N
    Microcirculation; 2010 Feb; 17(2):103-12. PubMed ID: 20163537
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of mTOR activity in diabetes mellitus reduces proteinuria but not renal accumulation of hyaluronan.
    Stridh S; Palm F; Takahashi T; Ikegami-Kawai M; Hansell P
    Ups J Med Sci; 2015; 120(4):233-40. PubMed ID: 26175092
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Glomerular hyperfiltration with hyperglycemia in the spontaneously diabetic Torii (SDT) fatty rat, an obese type 2 diabetic model.
    Sano R; Ishii Y; Yamanaka M; Yasui Y; Kemmochi Y; Kuroki F; Sugimoto M; Fukuda S; Sasase T; Miyajima K; Nakae D; Ohta T
    Physiol Res; 2021 Mar; 70(1):45-54. PubMed ID: 33453716
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hyperfiltration and diabetic nephropathy: is it the beginning? Or is it the end?
    Castellino P; Shohat J; DeFronzo RA
    Semin Nephrol; 1990 May; 10(3):228-41. PubMed ID: 2190280
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of unilateral nephrectomy on renal function of diabetic rats.
    Lopes GS; Lemos CC; Mandarim-De-Lacerda CA; Bregman R
    Histol Histopathol; 2004 Oct; 19(4):1085-8. PubMed ID: 15375750
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vasopressin contributes to hyperfiltration, albuminuria, and renal hypertrophy in diabetes mellitus: study in vasopressin-deficient Brattleboro rats.
    Bardoux P; Martin H; Ahloulay M; Schmitt F; Bouby N; Trinh-Trang-Tan MM; Bankir L
    Proc Natl Acad Sci U S A; 1999 Aug; 96(18):10397-402. PubMed ID: 10468619
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The characteristics of renal hemodynamics in diabetic spontaneously hypertensive rats in comparison with diabetic Wistar-Kyoto rats.
    Kaizu K; Ling QY; Uriu K; Ikeda M; Hashimoto O; Komine N; Eto S
    J Diabetes Complications; 1995; 9(4):224-6. PubMed ID: 8573732
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.